BioCentury
ARTICLE | Company News

Ark Therapeutics, University College London endocrine/metabolic news

May 14, 2012 7:00 AM UTC

Ark said that a consortium led by the college received a six-year grant of up to €6 million ($7.9 million) under the European Commission's Framework Programme 7 (FP7) to conclude preclinical toxicolog...